Literature DB >> 31532192

Repolarization of M2 to M1 Macrophages Triggered by Lactate Oxidase Released from Methylcellulose Hydrogel.

Zi-Xian Liao1, Yu-Chen Fa1, Ivan M Kempson2, S-Ja Tseng3,4.   

Abstract

Deregulated proliferation of tumors is generally associated with altered energy metabolism. A high rate of anaerobic glycolysis in solid tumors contributes to an acidification of pH to ∼6.7-7.2 in the tumor microenvironment and lactate accumulation. Macrophages in the tumor microenvironment can be educated by tumor cells. Tumor-derived lactate induces the polarization of M2 macrophages and promotes tumor invasion and metastasis. However, a particular challenge is to sustain lactate depletion. We propose that the repolarization of the tumor-supportive M2 macrophage to the tumor-suppressive M1 macrophage after the depletion of lactate by lactate oxidase (LOX) released from the hydrogels in the tumor microenvironment may enhance the antitumor treatment efficacy.

Entities:  

Year:  2019        PMID: 31532192     DOI: 10.1021/acs.bioconjchem.9b00618

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  11 in total

Review 1.  Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment.

Authors:  Mengyao Jin; Wei Cao; Bo Chen; Maoming Xiong; Guodong Cao
Journal:  Front Cell Dev Biol       Date:  2022-05-13

Review 2.  An update on mode of action of metformin in modulation of meta-inflammation and inflammaging.

Authors:  Meysam Khodadadi; Davoud Jafari-Gharabaghlou; Nosratollah Zarghami
Journal:  Pharmacol Rep       Date:  2022-01-24       Impact factor: 3.024

3.  Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models.

Authors:  Amber E de Groot; Kayla V Myers; Timothy E G Krueger; Ashley L Kiemen; Natalia H Nagy; Alexandria Brame; Vicente E Torres; Zhongyuan Zhang; Levent Trabzonlu; W Nathaniel Brennen; Denis Wirtz; Angelo M De Marzo; Sarah R Amend; Kenneth J Pienta
Journal:  Prostate       Date:  2021-05-05       Impact factor: 4.012

4.  Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition.

Authors:  Ruiqing He; Jie Zang; Yuge Zhao; Ying Liu; Shuangrong Ruan; Xiao Zheng; Gaowei Chong; Dailin Xu; Yan Yang; Yushan Yang; Tingting Zhang; Jingjing Gu; Haiqing Dong; Yongyong Li
Journal:  J Nanobiotechnology       Date:  2021-12-18       Impact factor: 10.435

Review 5.  Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy.

Authors:  Wei Cao; Mengyao Jin; Kang Yang; Bo Chen; Maoming Xiong; Xiang Li; Guodong Cao
Journal:  J Nanobiotechnology       Date:  2021-10-16       Impact factor: 10.435

Review 6.  A Review on the Design of Hydrogels With Different Stiffness and Their Effects on Tissue Repair.

Authors:  Tianyi Luo; Bowen Tan; Lengjing Zhu; Yating Wang; Jinfeng Liao
Journal:  Front Bioeng Biotechnol       Date:  2022-01-25

Review 7.  Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.

Authors:  Joy X Wang; Stephen Y C Choi; Xiaojia Niu; Ning Kang; Hui Xue; James Killam; Yuzhuo Wang
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

8.  lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer.

Authors:  Aitao Nai; Huihui Zeng; Qiong Wu; Zirui He; Shuwen Zeng; Shoaib Bashir; Feng Ma; Jie He; Wei Wan; Meng Xu
Journal:  Front Cell Dev Biol       Date:  2022-01-03

9.  Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase.

Authors:  Zi-Xian Liao; Da-Liang Ou; Ming-Jung Hsieh; Chia-Chen Hsieh
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

Review 10.  Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment.

Authors:  Yushuai Liu; Yuanyuan Geng; Beilei Yue; Pui-Chi Lo; Jing Huang; Honglin Jin
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.